EUVIMEDEUVIMED entdecken
Crossref

Hypoxia-Induced Myocardial Hypertrophy Companies with Apoptosis Enhancement and p38-MAPK Pathway Activation

Xiaoxu Li iD, Zhijun Pu iD, Gang Xu, Yidong Yang, Yu Cui, Xiaoying Zhou iD, Chenyuan Wang, Zhifeng Zhong, Simin Zhou, Jun Yin, Fabo Shan, Chengzhong Yang und 3 weitere

High Altitude Medicine & Biology · 2024

DOI: 10.1089/ham.2023.0036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift High Altitude Medicine & Biology, 2024. Verfasst von Xiaoxu Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of High Altitude Physiology & Pathology, College of High Altitude Military Medicine, Army Medical University (Third Military Medical Unive…. Hauptthemen laut MEDLINE: Apoptosis, Hypoxia, p38 Mitogen-Activated Protein Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisHypoxiap38 Mitogen-Activated Protein KinasesAnimalsMaleRatsCardiomegalyDisease Models, AnimalHemodynamicsHypertension, PulmonaryHypertrophy, Right VentricularHypoxia-Inducible Factor 1, alpha SubunitMAP Kinase Signaling SystemMyocardiumRats, Sprague-Dawley

Stichwörter der Autor:innen

apoptosishypobaric hypoxiamyocardial hypertrophyp38

Substanzen

Hif1a protein, ratHypoxia-Inducible Factor 1, alpha Subunitp38 Mitogen-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of High Altitude Physiology & Pathology, College of High Altitude Military Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
  • Key Laboratory of Extreme Environmental Medicine, Ministry of Education of China, Chongqing, China.
  • Key Laboratory of High-Altitude Medicine, Chongqing, China.
  • State Key Laboratory of Trauma, Burn and Combined Injury, Da-ping Hospital, Army Medical University, Chongqing, China.

ORCID-Profile: Xiaoxu Li, Zhijun Pu, Xiaoying Zhou

Zitieren

APA

Li, X., Pu, Z., Xu, G., Yang, Y., Cui, Y., Zhou, X., Wang, C., Zhong, Z., Zhou, S., Yin, J., Shan, F., Yang, C., Jiao, L., Chen, D., & Huang, J. (2024). Hypoxia-Induced Myocardial Hypertrophy Companies with Apoptosis Enhancement and p38-MAPK Pathway Activation. High Altitude Medicine & Biology. https://doi.org/10.1089/ham.2023.0036

Vancouver

Li X, Pu Z, Xu G, Yang Y, Cui Y, Zhou X, et al. Hypoxia-Induced Myocardial Hypertrophy Companies with Apoptosis Enhancement and p38-MAPK Pathway Activation. High Altitude Medicine & Biology. 2024. doi:10.1089/ham.2023.0036

BibTeX
@article{Li2024,
  author = {Li, Xiaoxu and Pu, Zhijun and Xu, Gang and Yang, Yidong and Cui, Yu and Zhou, Xiaoying and Wang, Chenyuan and Zhong, Zhifeng and Zhou, Simin and Yin, Jun and Shan, Fabo and Yang, Chengzhong and Jiao, Li and Chen, Dewei and Huang, Jian},
  title = {Hypoxia-Induced Myocardial Hypertrophy Companies with Apoptosis Enhancement and p38-MAPK Pathway Activation},
  journal = {High Altitude Medicine & Biology},
  year = {2024},
  doi = {10.1089/ham.2023.0036}
}
Kostenlos starten →